The coronavirus vaccine in the form of a spray developed by the biotechnology company CanSino Biologics based in China has been approved for use. The vaccine became the world’s first needle-free coronavirus vaccine.
the COVID-19 pandemic, which emerged at the end of 2019 and paralyzed the whole world, has largely lost its lethality with the effect of vaccination, but it still continues to be widely transmitted. Experts, while continuing to work on measures against the virus, news came from China today, which will be the first in the world.
China has approved the use of the world’s first needle-free coronavirus vaccine. The vaccine, developed by China-based ConSino Biologics, contains the same content as vaccines used in China. But the vaccine is not introduced into the human body through a needle but in the form of a nasal spray. The formula of the vaccine also contains genetic materials that will allow the human body to recognize the virus.
It provides 58% protection against COVID-19 with a single dose
According to the details shared, the vaccine takes advantage of a harmless version of the common cold virus to deliver information about the coronavirus to the body. According to the data shared by the World Health Organization, the vaccine provides 92% protection from the serious effects of COVID-19 with a single dose, while it provides 58% protection from the disease itself.
The data obtained in the clinical trials of the vaccine also showed that the vaccine in the form of a spray provides as much protection as the vaccines used in the Asian region offer in two doses. On the other hand, previous flu periods had shown that the vaccine in the form of a spray provided less protection than vaccines made with a needle. Exactly how effective the new coronavirus vaccine is will become clear with its widespread use of it.
